Clinical Trials Directory

Trials / Completed

CompletedNCT05120869

Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention

Implementing Innovative and Strategic Approaches to Prevent and Mitigate the Deleterious Effects of HPV Across the Lifespan of Hispanics of Mexican Origin: Healthcare Provider Intervention

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
178 (actual)
Sponsor
University of Texas, El Paso · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Healthcare providers (HCP) serving the El Paso U.S.-Mexico Border Region will be recruited to compare educational and professional skills interventions focused on the human papillomavirus (HPV). Our hypothesis is that improving provider knowledge and communication strategies about HPV and its vaccine will reduce hesitancy and increase uptake and completion among the populations they serve.

Detailed description

A sample of emerging \[in training\] and current \[in practice\] health professionals from the El Paso U.S.-Mexico Border Region will be recruited to participate in a human papillomavirus (HPV) educational and professional skills intervention. Hypothesis: improving provider knowledge and communication strategies about HPV and its vaccine will reduce hesitancy and increase uptake and completion among eligible individuals through a tailored multi-media intervention to strengthen providers' ability to discuss HPV and vaccination in an informed and culturally competent manner, and increase subsequent provider recommendations.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTailored HPV Education and Professional Skills Intervention GroupThe provider education and professional skills intervention will involve audio and visual content and will be delivered in the English language.
BEHAVIORALGeneral HPV Education and Communication Skills Control GroupThe general provider education intervention will involve audio and visual content and will be delivered in the English language.

Timeline

Start date
2023-12-22
Primary completion
2024-12-02
Completion
2024-12-02
First posted
2021-11-15
Last updated
2025-09-04

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05120869. Inclusion in this directory is not an endorsement.